Hepatolithiasis & Bile Duct Stones Diagnosis
Hepatolithiasis & Bile Duct Stones Diagnosis
Diagnosis of bile duct stones runs in a fixed sequence, and the order is not bureaucratic — each step decides whether the next is needed and what it should be. Blood tests say whether bile is obstructed and whether infection is in play. Ultrasound gives the first picture. MRCP maps every duct, stone and stricture before anything is treated, and it is the single most important examination in this disease. ERCP comes last, when it is a treatment rather than a look. Where stones have lived inside the liver for years, one more question is asked: what has the disease done to the liver itself?
Blood tests: the obstructive pattern
The first blood results say more about the ducts than any single scan:
- Bilirubin rising — the pigment backing up — together with alkaline phosphatase and GGT rising, the cholestatic enzymes, is the signature of obstruction.
- White cell count and CRP — the inflammation line; raised values with fever point to cholangitis.
- Blood cultures when cholangitis is suspected, to identify the bacteria driving it.
- Pancreas enzymes (amylase, lipase), because a stone at the lower end of the duct can inflame the pancreas.
- Clotting and liver-synthesis tests — how well the liver behind the blockage is still working.
Ultrasound: the first image
Ultrasound is almost always the first scan, and it earns its place:
- It shows dilated ducts — the stretching that happens above a block — often before the stone itself is seen.
- Stones in the main duct and in the gallbladder are usually visible; small intrahepatic stones can be missed, which is why a clear ultrasound does not end the workup when suspicion remains.
- It is fast, safe and repeatable — the right tool for the first hour of an attack.
- What it cannot do: see through bowel gas to the lower duct, or map the duct tree in enough detail to plan treatment. That detail work belongs to MRCP.
MRCP: the map the plan is written from
MRCP is an MRI scan tuned to show bile and pancreatic ducts, using no needles and no intervention. In this disease it is the pivotal examination:
- Every duct, every stone, every stricture — the whole tree, including the branches inside the liver that ultrasound can miss.
- The state of the liver around the diseased ducts — segments that have thinned, scarred or stopped contributing.
- The basis of the plan: how many sessions endoscopy will need, whether a stricture must be treated alongside the stone, and whether part of the disease is surgical rather than endoscopic at all.
- Why it comes before treatment, not during it: clearing a duct tree nobody has imaged is how stones get left behind and strictures get missed.
CT: what it adds
CT does not replace MRCP, and it is not routine for every stone. It earns its place in defined situations:
- Large stone loads, where the volume of disease matters to the choice between endoscopy and surgery.
- Liver change: segment atrophy, scarring, abscess — the complications of years of disease, seen more crisply than MRI gives them.
- The acute abdomen: when an attack is severe and the differential is wider, CT sorts the complications faster.
- Stones MRCP under-calls: some cholesterol-rich stones are hard to see on MRI and obvious on CT — the two scans correct each other.
ERCP: examination and treatment in one
ERCP passes a side-viewing endoscope to the mouth of the bile duct, and it is unique in this disease because it can treat while it examines:
- As treatment: cutting the muscular gate at the mouth of the duct (sphincterotomy), pulling stones out with balloons and baskets, and crushing stones too large to pull.
- As drainage: leaving a temporary internal stent or a nose-drain when a duct must be decompressed during infection.
- As diagnosis: only when something remains unexplained after MRCP — or when treatment is expected at the same sitting anyway.
- The order matters: during cholangitis, the first ERCP is for drainage; stones are cleared at a second sitting once the fever has settled, when it is also safer.
Assessing the liver before any decision
Where intrahepatic disease has run for years, one more layer of assessment decides what treatment is even on the table:
- Segment-by-segment review of the MRCP and CT: which segments hold stones, which ducts drain them, and which segments have scarred, thinned or stopped working.
- Liver reserve tests — blood measures of liver function — because the segments that remain have to carry the whole load, and removing diseased tissue is only sound when the remainder is healthy.
- The gallbladder — whether it holds stones and belongs to the same disease.
- The long-term risk line: ducts that have been inflamed for decades carry a raised risk of bile duct cancer, which is a reason long-standing disease is mapped and treated rather than indefinitely observed.
What your assessment visit looks like
Assessment is organised so that the plan, not the scan, is what you leave with:
- Before you travel: send the images themselves — MRCP especially — liver test results and the attack history; a written opinion follows within about 48 hours of complete records arriving.
- On arrival: a focused review of the duct map, blood tests to update the picture, and any missing scan arranged in a day or two.
- The plan you take home: which stones, which route — endoscopic, percutaneous, surgical or a combination — how many stages, how long the stay, and what follow-up looks like afterwards.